Latest News about PFE
Recent news which mentions PFE
Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
January 29, 2024
From Benzinga
A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now
January 29, 2024
From Motley Fool
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
From Benzinga
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
January 28, 2024
From Motley Fool
5 Magnificent Stocks to Buy That Are Dirt Cheap
January 28, 2024
From Motley Fool
2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now
January 27, 2024
From Motley Fool
3 Dividend Stocks to Buy and Hold for Long-Term Income in 2024
January 26, 2024
From InvestorPlace
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
From InvestorPlace
From Benzinga
3 Stocks to Sell Before Their Earnings Reports Disappoint in 2024
January 25, 2024
From InvestorPlace
What's Going On With Pfizer Stock Today?
January 25, 2024
From Benzinga
7 Over-Hyped Stocks to Sell Before They Plunge
January 25, 2024
From InvestorPlace
How Does Pfizer Fit Into a Well-Diversified Portfolio?
January 25, 2024
Tickers
PFE
From Motley Fool
These 2 Growth Stocks Down 37% and 47% Are Screaming Buys for 2024
January 25, 2024
From Motley Fool
Pfizer Options Trading: A Deep Dive into Market Sentiment
January 24, 2024
Tickers
PFE
From Benzinga
2 of the Best Stocks to Buy on a Dip in 2024
January 24, 2024
From Motley Fool
3 Growth Stocks Under $100 to Buy and Hold for Years
January 24, 2024
From Motley Fool
Why Pfizer Is a Much Better Stock Than You Might Think
January 24, 2024
Tickers
PFE
From Motley Fool
Maximizing Tax Deductions: 3 Charity-Friendly Stocks to Consider
January 23, 2024
From InvestorPlace
Bristol Myers, Exelixis Reveal 4-Year Follow-Up Results From Cancer Treatment Study
January 23, 2024
From Benzinga
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney Cancer Patients After 8 Years Of Followup
January 23, 2024
From Benzinga
From Benzinga
From Motley Fool
2 Incredible Growth Stocks That Are Screaming Buys for 2024
January 22, 2024
From Motley Fool
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
January 20, 2024
From Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
January 20, 2024
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
